Evidence map›Paper›PMID 19703463›Full record

ArticleJournal of molecular and cellular cardiology2009

Dietary omega-3 fatty acids alter cardiac mitochondrial phospholipid composition and delay Ca2+-induced permeability transition.

Karen M O'Shea, Ramzi J Khairallah, Genevieve C Sparagna, Wenhong Xu, Peter A Hecker, Isabelle Robillard-Frayne, Christine Des Rosiers, Tibor Kristian, Robert C Murphy, Gary Fiskum and 1 more

Abstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 91 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Karen M O'SheaDepartment of Nutrition, Case Western Reserve University, Cleveland, OH, USA.
Ramzi J Khairallah
Genevieve C Sparagna
Wenhong Xu
Peter A Hecker
Isabelle Robillard-Frayne
Christine Des Rosiers
Tibor Kristian
Robert C Murphy
Gary Fiskum
William C Stanley
University of Maryland, Baltimore · USMontreal Heart Institute · CAUniversité de Montréal · CAUniversity of Colorado Boulder · USUniversity of Colorado Denver · US

Funding

Substrate Selection and Oxidative Stress in Heart FailureP01HL074237 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI STANLEY, WILLIAM C · 2003 to 2013
$19.9M
Omega-3 Fatty Acids and Heart FailureR21HL091307 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI STANLEY, WILLIAM C · 2008 to 2009
$469k
NHLBI NIH HHS HL074237NHLBI NIH HHS HL091307NHLBI NIH HHS P01 HL074237NHLBI NIH HHS R21 HL091307
6 · The paper itself

Abstract

Consumption of omega-3 fatty acids from fish oil, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), decreases risk for heart failure and attenuates pathologic cardiac remodeling in response to pressure overload. Dietary supplementation with EPA + DHA may also impact cardiac mitochondrial function and energetics through alteration of membrane phospholipids. We assessed the role of EPA + DHA supplementation on left ventricular (LV) function, cardiac mitochondrial membrane phospholipid composition, respiration, and sensitivity to mitochondrial permeability transition pore (MPTP) opening in normal and infarcted myocardium. Rats were subjected to sham surgery or myocardial infarction by coronary artery ligation (n=10-14), and fed a standard diet, or supplemented with EPA + DHA (2.3% of energy intake) for 12 weeks. EPA + DHA altered fatty acid composition of total mitochondrial phospholipids and cardiolipin by reducing arachidonic acid content and increasing DHA incorporation. EPA + DHA significantly increased calcium uptake capacity in both subsarcolemmal and intrafibrillar mitochondria from sham rats. This treatment effect persisted with the addition of cyclosporin A, and was not accompanied by changes in mitochondrial respiration or coupling, or cyclophilin D protein expression. Myocardial infarction resulted in heart failure as evidenced by LV dilation and contractile dysfunction. Infarcted LV myocardium had decreased mitochondrial protein yield and activity of mitochondrial marker enzymes, however respiratory function of isolated mitochondria was normal. EPA + DHA had no effect on LV function, mitochondrial respiration, or MPTP opening in rats with heart failure. In conclusion, dietary supplementation with EPA + DHA altered mitochondrial membrane phospholipid fatty acid composition in normal and infarcted hearts, but delayed MPTP opening only in normal hearts.

Indexed as

AnimalsBody WeightCalciumCardiolipinsCell RespirationCyclosporineDietary FatsEchocardiographyFatty Acids, Omega-3MitochondriaMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PoreMyocardiumOrgan SizePhospholipidsRatsCalciumCardiolipinsCyclosporineDietary FatsFatty Acids, Omega-3Mitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PorePhospholipidsSuperoxides

Identifiers

PMID19703463
PMCPMC2783943
OpenAlexW2070332785

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.